Markets

Wall Street Wire

Sponsored company news and issuer-paid coverage. Wall Street Wire articles are paid promotional content; see each article’s disclaimer.

Duke Robotics Strengthens European Presence with New Greek Leadership Appointment
Wall Street Wire

Duke Robotics Strengthens European Presence with New Greek Leadership Appointment

Duke Robotics Corp. has appointed Alexandra Papaconstantinou as Managing Director of its Greek subsidiary, marking another milestone in the company’s European expansion strategy. The appointment comes just weeks after the establishment of Duke Robotics Hellas, the company’s first European branch. Papaconstantinou brings extensive experience in industrial engineering and

The Israeli Startup Redefining In-Game Advertising
Wall Street Wire

The Israeli Startup Redefining In-Game Advertising

The global gaming industry, now valued at approximately $188 billion, has become a dominant form of entertainment, particularly among younger audiences. Yet, despite its rapid expansion, monetization models have struggled to keep pace. Many existing approaches rely on disruptive pop-ups, forced video ads, or costly in-game purchases—methods

MedTech Innovator Inspira Advances AI-Powered Blood Monitoring Technology as Clinical Results Near
Wall Street Wire

MedTech Innovator Inspira Advances AI-Powered Blood Monitoring Technology as Clinical Results Near

In a landscape where medical technology increasingly intersects with artificial intelligence, Inspira Technologies (NASDAQ: IINN*) has announced a significant advancement in its blood monitoring platform. The Israeli medical device company has integrated a new oxygenation indicator into its AI-powered HYLA blood sensor, potentially eliminating the need for repeated blood

Actelis adds former Alcatel Corporate CTO & Celestea Capital Parter to Board
Wall Street Wire

Actelis adds former Alcatel Corporate CTO & Celestea Capital Parter to Board

Actelis Networks* (NASDAQ: ASNS), a provider of cyber-hardened networking solutions, has appointed Dr. Niel Ransom to its Board of Directors, bringing in a veteran with a strong background in network security, telecommunications, and deep-tech investments. His extensive experience in developing and scaling secure communications infrastructure is expected to

Market Leaders: Silexion’s Ilan Hadar Discusses Preclinical Milestones in KRAS-Driven Cancer Treatment, Market Momentum and Financing
Wall Street Wire

Market Leaders: Silexion’s Ilan Hadar Discusses Preclinical Milestones in KRAS-Driven Cancer Treatment, Market Momentum and Financing

Silexion Therapeutics* (NASDAQ: SLXN) is making strides in oncology with its RNAi-based treatment, SIL-204, targeting KRAS-driven cancers. In an interview on Market Leaders, CEO Ilan Hadar discussed the company’s recent breakthroughs and market activity. During the interview, Hadar highlighted that SIL-204 has shown promising preclinical